Table 2 Analysis of clinicopathological features and survival in univariate models.

Male

1.172 (0.676–2.032)

0.561

0.743 (0.370–1.491)

0.409

Age > 60

1.092 (0.634–1.880)

0.748

1.087 (0.5383–2.195)

0.814

ECOG2-4

1.387 (0.698–2.755)

0.299

1.496 (0.610–3.671)

0.316

B symptom

1.893 (1.045–3.429)

0.018

1.924 (0.912–4.058)

0.055

SD or PD

7.617 (2.993–19.38)

 < 0.001

5.710 (2.158–15.11)

 < 0.001

Stage (III–IV)

4.203 (2.390–7.394)

 < 0.001

2.927 (1.369–6.257)

0.033

LT ratio < 2

1.636 (0.909–2.944)

0.138

2.742 (1.269–5.924)

0.046

Hilum loss

2.309 (1.297–4.110)

0.017

4.147 (1.948–8.832)

0.010

Uncleared borders

3.566 (1.499–8.485)

 < 0.001

1.984 (0.7391–5.324)

0.084

Blend

1.653 (0.965–2.832)

0.117

1.874 (0.935–3.756)

0.091

Extra-nodal involvement > 2

1.810 (0.948–3.455)

0.072

3.708(1.292–10.642)

0.015

 β2-MG > 2.53

1.506 (0.869–2.611)

0.144

1.671 (0.8344–3.347)

0.144

 HB < 120 g/l

2.181 (1.246–3.816)

0.006

2.334 (1.163–4.684)

0.018

 LDH > ULN

3.005 (1.753–5.151)

 < 0.001

3.502 (1.751–7.003)

0.002